Insider: GSK plc    

Company Holdings AllWVECVRXBCYCNKTXPGNYLQDASPROTBIOCRSPTBPHFOLDDGX
  Direct Indirect Ownership Total
Shares 76,367,931 76,367,931
Value $ $3,796,891,351.08 $3,796,891,351.08
Ticker
Trans. Date
Trans. Type
Shares
Ownership Type
Issue Type
Price
Trans. Value
Total Shares Owned
WVE12/11/2025AAP1,470,000IndirectCOM$19.00$27,930,000.0018,245,691
WVE12/07/2023AAP3,300,000IndirectCOM$5.00$16,500,000.0013,983,761
CVRX07/02/2021AAP275,000IndirectCOM$18.00$4,950,000.001,007,583
BCYC07/15/2020DDS78IndirectCOM$19.25$1,501.501,910,531
BCYC07/15/2020DDS3,069IndirectCOM$19.40$59,543.511,910,609
NKTX07/14/2020AAP833,333IndirectCOM$18.00$14,999,994.003,150,732
BCYC07/14/2020DDS1,597IndirectCOM$19.27$30,780.581,913,678
PGNY05/20/2020DDS4,000,000IndirectCOM$25.75$103,000,000.006,238,244
LQDA07/30/2018AAP148,818IndirectCOM$11.00$1,636,998.00624,422
SPRO07/17/2018AAP80,000IndirectCOM$12.50$1,000,000.001,934,006
TBIO07/02/2018AAP269,230IndirectCOM$13.00$3,499,990.003,697,912
SPRO11/06/2017AAP428,571IndirectCOM$14.00$5,999,994.001,854,006
CRSP10/24/2016AAP66,500IndirectCOM$14.00$931,000.003,220,627
TBPH03/14/2016AAP1,301,015IndirectCOM$23,027,965.50$29,959,728,534,982.509,644,807
TBPH10/07/2015AAP44,574IndirectCOM$607,543.62$27,080,649,317.888,343,792
FOLD10/27/2014DDS11,315,825IndirectCOM$5.29$59,872,030.080
FOLD11/20/2013AAP1,500,000IndirectCOM$2.00$3,000,000.0011,315,825
FOLD07/17/2012AAP2,949,581IndirectCOM$6.30$18,582,360.309,815,825
DGX01/31/2011DDS15,377,551IndirectCOM$54.30$835,001,019.300
DGX01/31/2011DDS15,377,600IndirectCOM$55.62$855,225,224.0015,377,551
DGX03/19/2009DDS230,295IndirectCOM$44.36$10,216,001.3535,274,013
DGX03/19/2009DDS4,511,657IndirectCOM$44.33$199,999,950.1530,755,151
DGX03/19/2009DDS7,205IndirectCOM$45.24$325,960.6835,266,808
DGX03/18/2009DDS21,101IndirectCOM$46.40$979,170.8035,504,308
DGX03/18/2009DDS478,899IndirectCOM$45.67$21,872,849.8135,525,409
1   2  Next Last  You are at page 1 of 2 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel

Financial data provided by Zacks Investment Research. All information provided "as is" for informational purposes only. Neither Zacks nor any of its data or content providers shall be liable for any errors or delays in quotes, other content, or for any actions you take in reliance on this data or information.